Turk Ilac ve Serumnayi (IST:TRILC) YoY EBITDA Growth : 19.73% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Turk Ilac ve Serumnayi's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was 19.73%.

Turk Ilac ve Serumnayi's EBITDA per Share for the three months ended in Sep. 2023 was ₺0.44.

Turk Ilac ve Serumnayi YoY EBITDA Growth Historical Data

The historical data trend for Turk Ilac ve Serumnayi's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi YoY EBITDA Growth Chart

Turk Ilac ve Serumnayi Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EBITDA Growth

Get a 7-Day Free Trial

131.53

30.35

63.88

-2.37

101.31

Turk Ilac ve Serumnayi Quarterly Data
	Dec17	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
YoY EBITDA Growth	Get a 7-Day Free Trial														266.34	314.85	25.77	64.58	19.73

Turk Ilac ve Serumnayi YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Turk Ilac ve Serumnayi's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EBITDA Growth (A: Dec. 2022 )
=	(EBITDA per Share (A: Dec. 2022 )	-	EBITDA per Share (A: Dec. 2021 ))	/	\| EBITDA per Share (A: Dec. 2021 ) \|
=	(1.079	-	0.536)	/	\| 0.536 \|
=	101.31 %

Turk Ilac ve Serumnayi's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2023 )
=	(EBITDA per Share (Q: Sep. 2023 )	-	EBITDA per Share (Q: Sep. 2022 ))	/	\| EBITDA per Share (Q: Sep. 2022 )) \|
=	(0.443	-	0.37)	/	\| 0.37 \|
=	19.73 %

Turk Ilac ve Serumnayi YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750

Website

http://www.turkilac.com.tr

Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines